Castellier C, Doucède G, Debodinance P
Département de gynécologie-obstétrique, centre hospitalier Dunkerque, GCS Flandre-Maritime, avenue de la Polyclinique, 59760 Grande-Synthe, France.
J Gynecol Obstet Biol Reprod (Paris). 2013 Nov;42(7):639-46. doi: 10.1016/j.jgyn.2013.07.002. Epub 2013 Aug 20.
Evaluate the place of sub-urethral mini-slings in the treatment of female stress urinary incontinence.
Review of the literature on 43 publications (comparative and prospective studies) more than 6443 patients who underwent for the treatment of urinary incontinence, a mini-strip type TVT®, TVT-S®, MiniArc®, Ajust®, Needleless®, Solyx®, or Ophira® in comparison to the conventional urethral sling. The comparison used objective (cough stress test and pad weight test) and subjective criteria (quality of life questionnaire). The papers have also studied the complication associated with these new techniques.
The overall effectiveness of this surgery varied between 40 to 84% for TVT-S®, 69 to 92% for MiniArc®, 80 to 91% for Ajust®, 87% for Needleless®, 95% for Solyx® and 85% for Ophira®. The efficacy on incontinence was higher with the TVT® TVT-S® and the MiniArc® (P=0.01 to 0.05). TVT-O® efficacy was higher than TVT-S® (P<0.01 and P=0.02). Conventional slings seems to be more efficient than TVT-S® and MiniArc® mini-slings. Ajust® mini-sling seems to be as efficient as MiniArc® and TVT-S® mini-sling and TVT-O®. It showed a decrease in the intensity of postoperative pain (P<0.001), faster return to normal activities (P=0.025) and use of a common local anesthetic to the adjustable mini-sling.
It seems that the adjustable mini-sling is currently the best compromise in terms of effectiveness and complications if the choice had to be among the mini-sling in the treatment of stress urinary incontinence.
评估尿道下微型吊带术在女性压力性尿失禁治疗中的地位。
回顾43篇文献(对比研究和前瞻性研究),涉及6443例以上接受尿失禁治疗的患者,这些患者接受了微型条带式经阴道无张力尿道中段吊带术(TVT®)、TVT-S®、MiniArc®、Ajust®、无针式经阴道无张力尿道中段吊带术(Needleless®)、Solyx®或Ophira®,并与传统尿道吊带术进行比较。比较采用客观标准(咳嗽压力试验和尿垫重量试验)和主观标准(生活质量问卷)。这些文献还研究了与这些新技术相关的并发症。
该手术的总体有效率在TVT-S®为40%至84%、MiniArc®为69%至92%、Ajust®为80%至91%、Needleless®为87%、Solyx®为95%、Ophira®为85%之间。TVT®、TVT-S®和MiniArc®对尿失禁的疗效更高(P = 0.01至0.05)。TVT-O®的疗效高于TVT-S®(P < 0.01和P = 0.02)。传统吊带术似乎比TVT-S®和MiniArc®微型吊带术更有效。Ajust®微型吊带术似乎与MiniArc®、TVT-S®微型吊带术和TVT-O®一样有效。它显示术后疼痛强度降低(P < 0.001)、恢复正常活动更快(P = 0.025),并且可调节微型吊带使用普通局部麻醉剂。
如果必须在微型吊带术中选择治疗压力性尿失禁的方法,那么可调节微型吊带术目前似乎是在有效性和并发症方面的最佳折衷方案。